Literature DB >> 20890758

Anal carcinomas: the role of endoanal ultrasound and magnetic resonance imaging in staging, response evaluation and follow-up.

Jyoti Parikh1, Aidan Shaw, Lee A Grant, Alexis M P Schizas, Vivek Datta, Andrew B Williams, Nyree Griffin.   

Abstract

Anal carcinoma is an important but rare condition, managed in specialist centres. Both endoanal ultrasound and magnetic resonance imaging (MRI) can be used in the locoregional staging and follow-up of patients with anal cancer, and both may assist in treatment planning and prognosis. Recent guidelines published by the European Society for Medical Oncology have recommended MRI as the technique of choice for assessment of locoregional disease. This paper describes the techniques for both endoanal ultrasound and MRI, and compares the relative merits and disadvantages of each in the local assessment of anal carcinoma.

Entities:  

Mesh:

Year:  2010        PMID: 20890758     DOI: 10.1007/s00330-010-1980-7

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  21 in total

1.  Pelvic phased-array MR imaging of anal carcinoma before and after chemoradiation.

Authors:  D M Koh; A Dzik-Jurasz; B O'Neill; D Tait; J E Husband; G Brown
Journal:  Br J Radiol       Date:  2008-02       Impact factor: 3.039

Review 2.  Anal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Authors:  R Glynne-Jones; J Northover; J Oliveira
Journal:  Ann Oncol       Date:  2009-05       Impact factor: 32.976

3.  The impact of treatment factors on local control in T2-T3 anal carcinomas treated by radiotherapy with or without chemotherapy.

Authors:  A S Allal; B Mermillod; A D Roth; M C Marti; J M Kurtz
Journal:  Cancer       Date:  1997-06-15       Impact factor: 6.860

4.  Magnetic resonance imaging of anal cancer.

Authors:  S C Roach; P A Hulse; F J Moulding; R Wilson; B M Carrington
Journal:  Clin Radiol       Date:  2005-10       Impact factor: 2.350

5.  Endoscopic ultrasonography in the diagnosis, staging, and follow-up of anal carcinomas.

Authors:  B Magdeburg; M Fried; C Meyenberger
Journal:  Endoscopy       Date:  1999-06       Impact factor: 10.093

6.  Endoanal ultrasound in the staging and management of squamous-cell carcinoma of the anal canal: potential implications of a new ultrasound staging system.

Authors:  Debra Tarantino; Mitchell A Bernstein
Journal:  Dis Colon Rectum       Date:  2002-01       Impact factor: 4.585

7.  Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison.

Authors:  Gina Brown; Catherine J Richards; Michael W Bourne; Robert G Newcombe; Andrew G Radcliffe; Nicholas S Dallimore; Geraint T Williams
Journal:  Radiology       Date:  2003-05       Impact factor: 11.105

8.  Carcinoma of the anal canal. A clinical and pathologic study of 188 cases.

Authors:  B M Boman; C G Moertel; M J O'Connell; M Scott; L H Weiland; R W Beart; L L Gunderson; R J Spencer
Journal:  Cancer       Date:  1984-07-01       Impact factor: 6.860

Review 9.  Malignant anal tumours.

Authors:  G T Deans; J J McAleer; R A Spence
Journal:  Br J Surg       Date:  1994-04       Impact factor: 6.939

10.  Staging anal cancer: prospective comparison of transanal endoscopic ultrasound and magnetic resonance imaging.

Authors:  S D Otto; L Lee; H J Buhr; B Frericks; S Höcht; A J Kroesen
Journal:  J Gastrointest Surg       Date:  2009-04-14       Impact factor: 3.452

View more
  15 in total

1.  Anal cancer - a review.

Authors:  Sajad Ahmad Salati; Azzam Al Kadi
Journal:  Int J Health Sci (Qassim)       Date:  2012-06

Review 2.  The differential diagnosis and interdisciplinary treatment of anal carcinoma.

Authors:  Dimitrios Raptis; Ignaz Schneider; Klaus E Matzel; Oliver Ott; Rainer Fietkau; Werner Hohenberger
Journal:  Dtsch Arztebl Int       Date:  2015-04-03       Impact factor: 5.594

Review 3.  Multimodality Imaging Review of Anorectal and Perirectal Diseases With Histological, Endoscopic, and Operative Correlation, Part I: Anatomy and Neoplasms.

Authors:  Guillermo P Sangster; David H Ballard; Miguel Nazar; Richard Tsai; Maren Donato; Horacio B D'Agostino
Journal:  Curr Probl Diagn Radiol       Date:  2018-07-29

4.  The role of MRI in the assessment of the local status of anal carcinomas and in their management.

Authors:  É Jederán; J Lővey; Z Szentirmai; E Hitre; G Léránt; K Horváth; M Gődény
Journal:  Pathol Oncol Res       Date:  2014-10-30       Impact factor: 3.201

5.  Utility of PET Scans in the Diagnosis and Management of Gastrointestinal Tumors.

Authors:  Nandakumar Menon; Mark Mandelkern
Journal:  Dig Dis Sci       Date:  2022-07-30       Impact factor: 3.487

Review 6.  Anal cancer: are we making progress?

Authors:  Ajay Aggarwal; Simon Duke; Rob Glynne-Jones
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

Review 7.  Anorectal Cancer: Critical Anatomic and Staging Distinctions That Affect Use of Radiation Therapy.

Authors:  Shanna A Matalon; Harvey J Mamon; Charles S Fuchs; Leona A Doyle; Sree Harsha Tirumani; Nikhil H Ramaiya; Michael H Rosenthal
Journal:  Radiographics       Date:  2015 Nov-Dec       Impact factor: 5.333

8.  MITHRA - multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: a feasibility study.

Authors:  Luca Tagliaferri; Stefania Manfrida; Brunella Barbaro; Maria Maddalena Colangione; Valeria Masiello; Gian Carlo Mattiucci; Elisa Placidi; Rosa Autorino; Maria Antonietta Gambacorta; Silvia Chiesa; Giovanna Mantini; György Kovács; Vincenzo Valentini
Journal:  J Contemp Brachytherapy       Date:  2015-10-19

9.  MRI and CT of anal carcinoma: a pictorial review.

Authors:  Massimo Tonolini; Roberto Bianco
Journal:  Insights Imaging       Date:  2012-12-04

Review 10.  Management of persistent anal canal carcinoma after combined-modality therapy: a clinical review.

Authors:  Daniela Musio; Francesca De Felice; Nicola Raffetto; Vincenzo Tombolini
Journal:  Radiat Oncol       Date:  2014-01-28       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.